At the European Association of Urology Congress 2026 (EAU26), we hosted the session “Understanding and overcoming patient barriers to discussing urinary symptoms linked to bladder cancer.” The session explored why some people delay seeking medical advice when experiencing urinary symptoms and what can be done to support earlier diagnosis.
During the session, our Executive Director, Alex Filicevas, presented research examining the behavioural factors that influence whether people seek medical care when experiencing urinary symptoms that could be linked to bladder cancer.
At the European Association of Urology Congress 2026 (EAU26), we presented the BCLEAR (Bladder Cancer Literacy for All) project during the session “Health Literacy in Bladder Cancer” at the Patient Advocacy Plaza. The session explored how improving health literacy can help people recognise symptoms earlier, better understand their diagnosis and participate more actively in decisions about their care.
During the session, our Executive Director, Alex Filicevas, together with Renée Leenen,
At the European Association of Urology Congress 2026 (EAU26), the session “Living with urinary incontinence as a comorbidity: patient perspectives” explored an important but often overlooked issue for people affected by bladder cancer: urinary continence and its impact on everyday life.
Urinary incontinence can occur as a result of the disease itself or as a consequence of treatments such as surgery or urinary reconstruction. While the focus of care is often on treating the cancer,
At the European Association of Urology Congress 2026 (EAU26), we participated in the session “BCLEAR: Shared Decisions, Stronger Care in Bladder Cancer – Addressing Clinician Needs Across Europe”. The session brought together clinicians, primary care representatives and patient advocates to discuss how shared decision-making can be strengthened across the bladder cancer care pathway.
During the session, WBCPC Executive Director Alex Filicevas, presented insights from the Global Bladder Cancer Patient and Carer Survey,
The World Bladder Cancer Patient Coalition (WBCPC) is attending the European Association of Urology Congress 2026, one of the world’s leading events in urology, where patient advocacy and patient perspectives are increasingly recognised as an essential part of improving cancer care.
Today, during EAU Patient Day, WBCPC contributed to the Patient Advocacy Poster Session, which showcases initiatives from patient organisations working to strengthen awareness, diagnosis and patient support.
From 13–16 March 2026, the World Bladder Cancer Patient Coalition (WBCPC) will be attending the European Association of Urology (EAU) Congress in London, one of the largest international meetings dedicated to urology research, clinical practice and patient care.
For the bladder cancer community, the presence of WBCPC at EAU is important. It ensures that the patient perspective is represented in conversations where new research is presented and where clinical pathways and care approaches are discussed.
The World Bladder Cancer Patient Coalition (WBCPC) took part in the 2026 edition of the ASCO Genitourinary Cancers Symposium, held in San Francisco from February 27–29, 2026. This international meeting brings together clinicians, researchers and organisations working in genitourinary (GU) cancers, including bladder cancer, to share the latest scientific developments and clinical updates.
This year, our Executive Director, Alex Filicevas, presented a poster titled: “Fostering Inclusive Language in Genitourinary Cancer Research” during the Prostate Cancer and Urothelial Carcinoma session.
On the occasion of World Cancer Day , the World Bladder Cancer Patient Coalition (WBCPC) is once again joining forces with the global cancer community to raise awareness. This year, under the theme “United by Unique”, we invite everyone to shine a spotlight on bladder cancer and advocate for equitable, people-centred care for all. World Cancer Day is led by the Union for International Cancer Control (UICC) and is now in the second year of a three-year campaign focusing on people-centred care.
WBCPC took part in a special meeting of the European Parliament Intergroup on Cancer and Rare Diseases on the eve of World Cancer Day. Members of the European Parliament, patient organisations, healthcare professionals, and civil society representatives joined the discussion as negotiations begin on the next Multiannual Financial Framework for 2028 to 2034.
Participants discussed how the EU can sustain the momentum created by Europe’s Beating Cancer Plan and the EU Mission on Cancer.
